23.27
Inhibrx Biosciences Inc Aktie (INBX) Neueste Nachrichten
What analysts say about Inhibrx Biosciences Inc. stockExceptional gains - Autocar Professional
T.T. Limited (TTL) vs yyyExceptional earning trajectories - jammulinksnews.com
What analysts say about Appian Corporation stockRecord-setting profit potential - jammulinksnews.com
Top Quality Stocks Trusted Financial InsightsSuperior risk-adjusted returns - jammulinksnews.com
Is CAPL a good long term investmentOutstanding capital appreciation - jammulinksnews.com
Is Inhibrx Biosciences Inc. a good long term investmentTriple-digit returns - jammulinksnews.com
What drives Inhibrx Biosciences Inc. stock priceRapid return acceleration - jammulinksnews.com
How Technology Stocks Are Reshaping India’s Market Insider Stock RecommendationsTremendous return rates - Autocar Professional
Inhibrx Biosciences Inc. Stock Analysis and ForecastGame-changing returns - jammulinksnews.com
Top Stocks for Hedge Fund Investments Elite Trader Market TipsBreakthrough profit margins - printweek.in
Best Stocks for Aggressive Investors in India High Value Stock PicksBreakthrough profits - Autocar Professional
why ivda stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
What drives SERV stock priceHigh-performance investment picks - jammulinksnews.com
What drives PLAB stock priceExceptional stock performance - jammulinksnews.com
Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype - Seeking Alpha
Why Inhibrx Biosciences Inc. stock attracts strong analyst attentionHigh Return Setup Scanner - beatles.ru
What makes Inhibrx Biosciences Inc. stock price move sharplyROI Driven Alerts - Newser
How Inhibrx Biosciences Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
(INBX) Trading Signals - news.stocktradersdaily.com
Why INBX Is A Stock To Watch In 2025 - RTTNews
Inhibrx Biosciences, Inc.(NasdaqGS: INBX) dropped from Russell Microcap Growth Index - MarketScreener
How To Trade (INBX) - news.stocktradersdaily.com
Inhibrx Biosciences, Inc.(NasdaqGS: INBX) added to Russell 2000 Defensive Index - MarketScreener
Inhibrx Biosciences Concludes 2025 Annual Stockholders Meeting - TipRanks
Inhibrx Reports First Quarter 2025 Financial Results - BioSpace
Inhibrx Slashes Q1 Losses by 45%, Reveals Multiple Clinical Trial Readouts Coming in 2025 - Stock Titan
Oropharyngeal Cancer Treatment Market Size in 7MM is expected - openPR.com
Larynx Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight - openPR.com
Oropharyngeal Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight - Barchart.com
When the Price of (INBX) Talks, People Listen - news.stocktradersdaily.com
(INBX) On The My Stocks Page - news.stocktradersdaily.com
Change at the top for Phathom as Basta replaces Curran - biocentury.com
Inhibrx Biosciences reshuffles leadership, appoints new CSO and President By Investing.com - Investing.com South Africa
Inhibrx Biosciences reshuffles leadership, appoints new CSO and President - Investing.com India
Inhibrx Biosciences Announces Departure Of CSO And Appointments Of New CSO And President - TradingView
Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President - PR Newswire
How the (INBX) price action is used to our Advantage - news.stocktradersdaily.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):